Biopharmaceutical formulations for pre-filled delivery devices
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Pre-filled syringes are becoming an increasingly popular format for delivering biotherapeutics conveniently and cost effectively. The device design and stable liquid formulations required to enable this pre-filled syringe format are technically challenging. In choosing the materials and process conditions to fabricate the syringe unit, their compatibility with the biotherapeutic needs to be carefully assessed. The biothereaputic stability demanded for the production of syringe-compatible low-viscosity liquid solutions requires critical excipient choices to be made. AREAS COVERED: The purpose of this review is to discuss key issues related to the stability aspects of biotherapeutics in pre-filled devices. This includes effects on both physical and chemical stability due to a number of stress conditions the product is subjected to, as well as interactions with the packaging system. Particular attention is paid to the control of stability by formulation. EXPERT OPINION: We anticipate that there will be a significant move towards polymer primary packaging for most drugs in the longer term. The timescales for this will depend on a number of factors and hence will be hard to predict. Formulation will play a critical role in developing successful products in the pre-filled syringe format, particularly with the trend towards concentrated biotherapeutics. Development of novel, smart formulation technologies will, therefore, be increasingly important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355 · cited 3×
“Aggregation is the degradation pathway of primary concern [48,49] as it can lead to the loss of biological activity [47,50] as well as immunogenic reactions [51-53].”
BackgroundIsmael, G., Hegg, R., Muehlbauer, S., Heinzmann, D., Lum, B., Kim, S.-B., Pienkowski, T., Lichinitser, M., Semiglazov, V., Melichar, B., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70329-7 · Cited by 351 · cited 1×
“This technology is being implemented, in collaboration with Roche, to the development of a subcutaneous formulation of the cancer drug Herceptin [146,147].”
MethodGlycation of monoclonal antibodies impairs their ability to bind antigen
KENNEDY, D. M., SKILLBN, A. W., & SELF, C. H. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06133.x · Cited by 74 · cited 1×
“Such products can lead to the discolouration of the composition and affect the potency [17].”
Background
Cited by
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Protein Aggregation and Particle Formation in Prefilled Glass Syringes
Gerhardt, A., Mcgraw, N. R., Schwartz, D. K., Bee, J. S., Carpenter, J. F., & Randolph, T. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23973 · Cited by 197
Chisholm, C. F., Nguyen, B. H., Soucie, K. R., Torres, R. M., Carpenter, J. F., & Randolph, T. W. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24573 · Cited by 55
Gikanga, B., Turok, R., Hui, A., Bowen, M., Stauch, O. B., & Maa, Y.-F. (2015) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2015.01003 · Cited by 51
Chisholm, C. F., Soucie, K. R., Song, J. S., Strauch, P., Torres, R. M., Carpenter, J. F., Ragheb, J. A., & Randolph, T. W. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.02.008 · Cited by 31
Metadata
- Authors
- Jezek, J., Darton, N. J., Derham, B. K., Royle, N., & Simpson, I.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-03-19
- Volume
- 10
- Issue
- 6
- Pages
- 811-828
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2119981428
- Cited by
- 72
- References
- 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biopharmaceutical formulations for pre-filled delivery devices. https://app.cochat.ai/papers/10.1517/17425247.2013.780023
- The paper
- Jezek, J., Darton, N. J., Derham, B. K., Royle, N., & Simpson, I. (2013). Biopharmaceutical formulations for pre-filled delivery devices. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2013.780023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.